<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; Diversity Libraries</title>
	<atom:link href="http://www.bioscreening.net/category/news/diversity-libraries/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>BioFocus to Offer IMD’s Natural Product Libraries through Drug Discovery Services</title>
		<link>http://www.bioscreening.net/2011/08/02/biofocus-to-offer-imd%e2%80%99s-natural-product-libraries-through-drug-discovery-services/</link>
		<comments>http://www.bioscreening.net/2011/08/02/biofocus-to-offer-imd%e2%80%99s-natural-product-libraries-through-drug-discovery-services/#comments</comments>
		<pubDate>Tue, 02 Aug 2011 16:44:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Natural Products]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1227</guid>
		<description><![CDATA[BioFocus and InterMed Discovery (IMD) inked a marketing collaboration that will allow BioFocus to offer IMD’s natural product screening libraries through its drug discovery services. IMD will in addition provide follow-on services to BioFocus. “We have been impressed with the scale of IMD’s natural product discovery capabilities, and we believe that when InterMed’s natural product [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/02/biofocus-to-offer-imd%e2%80%99s-natural-product-libraries-through-drug-discovery-services/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fragment Library</title>
		<link>http://www.bioscreening.net/2010/12/20/fragment-library/</link>
		<comments>http://www.bioscreening.net/2010/12/20/fragment-library/#comments</comments>
		<pubDate>Mon, 20 Dec 2010 18:59:24 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1069</guid>
		<description><![CDATA[Thermo Fisher Scientific Inc. announced that its Maybridge Ro3 Diversity Fragment Library has helped researchers validate an emerging technique for drug discovery that targets key protein receptors involved in a wide range of biological functions. David Myszka, founder of Biosensor Tools LLC and director of the Center for Biomolecular Interaction Analysis at the University of [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/12/20/fragment-library/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sirona Biochem Says SGLT Test Results Confirm Key &#8216;Breakthrough&#8217;</title>
		<link>http://www.bioscreening.net/2009/10/09/sirona-biochem-says-sglt-test-results-confirm-key-breakthrough/</link>
		<comments>http://www.bioscreening.net/2009/10/09/sirona-biochem-says-sglt-test-results-confirm-key-breakthrough/#comments</comments>
		<pubDate>Fri, 09 Oct 2009 16:02:51 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Cell-based Assays]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/10/09/sirona-biochem-says-sglt-test-results-confirm-key-breakthrough/</guid>
		<description><![CDATA[Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on diabetes and obesity, says results of testing its unique SGLT inhibitor molecules demonstrate a key breakthrough milestone for Sirona Biochem. Sirona Biochem CEO, Dr. Howard Verrico, said, &#8220;There are two vital steps in the early stage of drug testing: validation of concept i.e. a [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/10/09/sirona-biochem-says-sglt-test-results-confirm-key-breakthrough/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioLeap Wins GlaxoSmithKline Contract to Design Novel Lead Compounds for Previously Intractable Targets for Important Unmet Medical Needs.</title>
		<link>http://www.bioscreening.net/2009/09/09/bioleap-wins-glaxosmithkline-contract-to-design-novel-lead-compounds-for-previously-intractable-targets-for-important-unmet-medical-needs/</link>
		<comments>http://www.bioscreening.net/2009/09/09/bioleap-wins-glaxosmithkline-contract-to-design-novel-lead-compounds-for-previously-intractable-targets-for-important-unmet-medical-needs/#comments</comments>
		<pubDate>Wed, 09 Sep 2009 14:34:45 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Grants and Awards]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/09/09/bioleap-wins-glaxosmithkline-contract-to-design-novel-lead-compounds-for-previously-intractable-targets-for-important-unmet-medical-needs/</guid>
		<description><![CDATA[BioLeap and GSK have entered into an agreement whereby BioLeap will design novel lead compounds for "difficult" drug targets. The targets (not disclosed) are ones for which conventional approaches, like high throughput screening, have failed to yield a viable chemical starting point. Typically these are in areas of high unmet medical need. BioLeap will use [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/09/09/bioleap-wins-glaxosmithkline-contract-to-design-novel-lead-compounds-for-previously-intractable-targets-for-important-unmet-medical-needs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TimTec Expands Partnership With Collaborative Drug Discovery Through Publishing Three Additional Libraries on CDD&#8217;s Free Public Access Database</title>
		<link>http://www.bioscreening.net/2009/05/13/timtec-expands-partnership-with-collaborative-drug-discovery-through-publishing-three-additional-libraries-on-cdds-free-public-access-database/</link>
		<comments>http://www.bioscreening.net/2009/05/13/timtec-expands-partnership-with-collaborative-drug-discovery-through-publishing-three-additional-libraries-on-cdds-free-public-access-database/#comments</comments>
		<pubDate>Wed, 13 May 2009 19:56:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/05/13/timtec-expands-partnership-with-collaborative-drug-discovery-through-publishing-three-additional-libraries-on-cdds-free-public-access-database/</guid>
		<description><![CDATA[Last October, TimTec and Collaborative Drug Discovery (CDD) established a collaboration in which CDD&#8217;s web-based data management system would host two TimTec Natural Products libraries on their free communityÂ Public AccessÂ site. Â Through this partnership, researchers would be able to register for a free account with CDD allowing them to chemically mine the contents of these TimTec [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/05/13/timtec-expands-partnership-with-collaborative-drug-discovery-through-publishing-three-additional-libraries-on-cdds-free-public-access-database/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>3rd International Symposium on Advances in Synthetic and Medicinal Chemistry</title>
		<link>http://www.bioscreening.net/2009/05/10/3rd-international-symposium-on-advances-in-synthetic-and-medicinal-chemistry/</link>
		<comments>http://www.bioscreening.net/2009/05/10/3rd-international-symposium-on-advances-in-synthetic-and-medicinal-chemistry/#comments</comments>
		<pubDate>Mon, 11 May 2009 02:19:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Heterocyclic Chemistry]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/05/10/3rd-international-symposium-on-advances-in-synthetic-and-medicinal-chemistry/</guid>
		<description><![CDATA[Kiev, Ukraine, August 23 &#8211; 27, 2009 ASMC09 in Kiev is being prepared by EFMC (European Federation for Medicinal Chemistry) and ChemBridge Corporation, in the series of events which started with ASCMC04 Moscow followed by ASMC07 St. Petersburg. Prof. Erick Carreira, ETH Zurich, Switzerland and Dr Scott Biller, Novartis Institutes for BioMedical Research, Cambridge, USA, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/05/10/3rd-international-symposium-on-advances-in-synthetic-and-medicinal-chemistry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Thermo Fisher Scientific Accelerates Drug Discovery Process With New Maybridge Quick2Leadâ„¢ Compound Kits</title>
		<link>http://www.bioscreening.net/2009/03/27/thermo-fisher-scientific-accelerates-drug-discovery-process-with-new-maybridge-quick2lead%e2%84%a2-compound-kits/</link>
		<comments>http://www.bioscreening.net/2009/03/27/thermo-fisher-scientific-accelerates-drug-discovery-process-with-new-maybridge-quick2lead%e2%84%a2-compound-kits/#comments</comments>
		<pubDate>Sat, 28 Mar 2009 01:32:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/03/27/thermo-fisher-scientific-accelerates-drug-discovery-process-with-new-maybridge-quick2lead%e2%84%a2-compound-kits/</guid>
		<description><![CDATA[Thermo Fisher Scientific, the world leader in serving science, announced recently that it has introduced a novel tool to accelerate hit-to-lead programmes in the drug discovery process. Its Maybridge Quick2Leadâ„¢ Compound Kits are designed to save time and money by enabling rapid compound library synthesis around bioactive &#8220;hits&#8221; emerging from screening assays. The kits are [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/03/27/thermo-fisher-scientific-accelerates-drug-discovery-process-with-new-maybridge-quick2lead%e2%84%a2-compound-kits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fragment Based Screening Service at CRELUX and ZoBio</title>
		<link>http://www.bioscreening.net/2008/11/27/fragment-based-screening-service-at-crelux-and-zobio/</link>
		<comments>http://www.bioscreening.net/2008/11/27/fragment-based-screening-service-at-crelux-and-zobio/#comments</comments>
		<pubDate>Fri, 28 Nov 2008 02:04:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/27/fragment-based-screening-service-at-crelux-and-zobio/</guid>
		<description><![CDATA[Munich (D) and Leiden (NL), November 24, 2008 / b3c newswire /Â  â€“ CRELUX and ZoBio announced today that they have successfully executed their first fragment based screening projects from a jointly established platform. One of the first targets, which also will be made accessible to customers, was Pim1, a kinase that has been implicated [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/27/fragment-based-screening-service-at-crelux-and-zobio/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>4th Annual International Conference on Compound Libraries &#8211; in Dusseldorf, Germany from 6th to 8th October 2008.</title>
		<link>http://www.bioscreening.net/2008/07/01/4th-annual-international-conference-on-compound-libraries-in-dusseldorf-germany-from-6th-to-8th-october-2008/</link>
		<comments>http://www.bioscreening.net/2008/07/01/4th-annual-international-conference-on-compound-libraries-in-dusseldorf-germany-from-6th-to-8th-october-2008/#comments</comments>
		<pubDate>Tue, 01 Jul 2008 17:46:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/01/4th-annual-international-conference-on-compound-libraries-in-dusseldorf-germany-from-6th-to-8th-october-2008/</guid>
		<description><![CDATA[From Focused Compound Libraries to optimised Hit-to-Lead &#8211; that&#8217;s the motto of IQPC&#8217;s 4th international conference on &#8220;Compound Libraries&#8221; (formerly &#8220;Focused Compound Libraries&#8221;). Nowadays the pharmaceutical industry is under enormous pressure, and the key for the industry to survive is faster and more efficient drug discovery. To improve their lead generation process and library, pharmaceutical [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/01/4th-annual-international-conference-on-compound-libraries-in-dusseldorf-germany-from-6th-to-8th-october-2008/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery</title>
		<link>http://www.bioscreening.net/2008/04/09/spermatech-selects-evotec-as-partner-for-high-throughput-screening-and-lead-discovery-2/</link>
		<comments>http://www.bioscreening.net/2008/04/09/spermatech-selects-evotec-as-partner-for-high-throughput-screening-and-lead-discovery-2/#comments</comments>
		<pubDate>Wed, 09 Apr 2008 16:30:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/04/09/spermatech-selects-evotec-as-partner-for-high-throughput-screening-and-lead-discovery-2/</guid>
		<description><![CDATA[Hamburg, Germany &#124; Oxford, UK &#124; Oslo, Norway &#8211; Evotec AG (Frankfurt Stock Exchange: EVT) announced today that Spermatech A/S has chosen them as a partner to identify small molecule therapeutics for their pharmaceutical discovery project. Through the study of the physiology of sperm motility, more specifically of &#8220;rapid swimmers&#8221; that cause fertilisation, Spermatech have [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/04/09/spermatech-selects-evotec-as-partner-for-high-throughput-screening-and-lead-discovery-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bucks County&#8217;s Institute for Hepatitis and Virus Research and BioLeap Collaborate on New Discoveries</title>
		<link>http://www.bioscreening.net/2007/10/18/bucks-countys-institute-for-hepatitis-and-virus-research-and-bioleap-collaborate-on-new-discoveries/</link>
		<comments>http://www.bioscreening.net/2007/10/18/bucks-countys-institute-for-hepatitis-and-virus-research-and-bioleap-collaborate-on-new-discoveries/#comments</comments>
		<pubDate>Thu, 18 Oct 2007 17:30:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Hepatitis Research]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/18/bucks-countys-institute-for-hepatitis-and-virus-research-and-bioleap-collaborate-on-new-discoveries/</guid>
		<description><![CDATA[New Hope, PA &#8212; (SBWIRE) &#8212; 10/10/2007 &#8212; Bucks Countyâ€™s Institute for Hepatitis and Virus Research (IHVR) and BioLeap have entered into a collaboration to develop new therapeutic compounds for the treatment of Hepatitis C. Up to 50% of patients treated with current standard therapies do not respond adequately and often suffer serious side effects [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/18/bucks-countys-institute-for-hepatitis-and-virus-research-and-bioleap-collaborate-on-new-discoveries/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dr. Stephen Burley, SGX Pharmaceuticalsâ€“Keynote speaker at 3rd Modern Drug Discovery &amp; Development</title>
		<link>http://www.bioscreening.net/2007/10/18/dr-stephen-burley-sgx-pharmaceuticals%e2%80%93keynote-speaker-at-3rd-modern-drug-discovery-development/</link>
		<comments>http://www.bioscreening.net/2007/10/18/dr-stephen-burley-sgx-pharmaceuticals%e2%80%93keynote-speaker-at-3rd-modern-drug-discovery-development/#comments</comments>
		<pubDate>Thu, 18 Oct 2007 17:26:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/18/dr-stephen-burley-sgx-pharmaceuticals%e2%80%93keynote-speaker-at-3rd-modern-drug-discovery-development/</guid>
		<description><![CDATA[(PRLog.Org) â€“ Oct 17, 2007 â€“ MONROVIA, CA â€“ Dr. Stephen K. Burley, Chief Scientific Officer and Senior Vice-President Research at SGX Pharmaceuticals, Inc. located in San Diego, CA will give the Keynote presentation at GTCbioâ€™s Drug Design &#038; Lead Discovery conference â€“ one of six tracks at the 3rd Modern Drug Discovery &#038; Development [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/18/dr-stephen-burley-sgx-pharmaceuticals%e2%80%93keynote-speaker-at-3rd-modern-drug-discovery-development/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Key Organics Ltd and Reaction Biology Corporation Announce New Library Screening Format</title>
		<link>http://www.bioscreening.net/2006/06/01/key-organics-ltd-and-reaction-biology-corporation-announce-new-library-screening-format/</link>
		<comments>http://www.bioscreening.net/2006/06/01/key-organics-ltd-and-reaction-biology-corporation-announce-new-library-screening-format/#comments</comments>
		<pubDate>Thu, 01 Jun 2006 22:23:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2006/06/01/key-organics-ltd-and-reaction-biology-corporation-announce-new-library-screening-format/</guid>
		<description><![CDATA[CORNWALL, England and MALVERN, Pa., June 1 /PRNewswire/ &#8212; Key Organics Ltd (&#8220;Key&#8221;) and Reaction Biology Corporation (&#8220;RBC&#8221;) today announced that they have teamed up to provide a new library screening format to customers. Beginning this summer, the entire Key Bionet library of 37,500 diverse drug-like compounds will be offered for &#8220;rental&#8221; screening on RBC&#8217;s [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2006/06/01/key-organics-ltd-and-reaction-biology-corporation-announce-new-library-screening-format/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Elsevier MDL and Key Organics partner to improve chemical sourcing</title>
		<link>http://www.bioscreening.net/2006/05/10/elsevier-mdl-and-key-organics-partner-to-improve-chemical-sourcing/</link>
		<comments>http://www.bioscreening.net/2006/05/10/elsevier-mdl-and-key-organics-partner-to-improve-chemical-sourcing/#comments</comments>
		<pubDate>Wed, 10 May 2006 16:07:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Natural Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2006/05/10/elsevier-mdl-and-key-organics-partner-to-improve-chemical-sourcing/</guid>
		<description><![CDATA[San Ramon, CA, May 8, 2006 &#8211; Elsevier MDL, producer of the MDLÂ® Available Chemicals Directory and MDLÂ® Screening Compounds Directory databases, and Key Organics Ltd., a leading supplier of screening compounds and chemical building blocks, have partnered in an effort to provide improved access to timely, accurate information for chemical sourcing and procurement for [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2006/05/10/elsevier-mdl-and-key-organics-partner-to-improve-chemical-sourcing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TimTec announces 10-year anniversary</title>
		<link>http://www.bioscreening.net/2005/10/17/timtec-10-year-anniversary/</link>
		<comments>http://www.bioscreening.net/2005/10/17/timtec-10-year-anniversary/#comments</comments>
		<pubDate>Mon, 17 Oct 2005 17:20:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/10/17/timtec-10-year-anniversary/</guid>
		<description><![CDATA[October 17, 2005 TIMTEC INC, Delawareâ€”TimTec Inc. is expressing customer and business partner appreciation as the company marks 10-years anniversary on the market of early drug-discovery. Ten years in business, TimTec has matured into an internationally recognized expert in comprising diversity and targeted library collections tailored to fit drug discovery trends. Presently the company features [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/10/17/timtec-10-year-anniversary/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sigma-Aldrich Introduces the MyriaScreen Diversity Collection for Drug Discovery</title>
		<link>http://www.bioscreening.net/2005/09/23/sigma-aldrich-introduces-the-myriascreen-diversity-collection-for-drug-discovery-2/</link>
		<comments>http://www.bioscreening.net/2005/09/23/sigma-aldrich-introduces-the-myriascreen-diversity-collection-for-drug-discovery-2/#comments</comments>
		<pubDate>Fri, 23 Sep 2005 16:58:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/09/23/sigma-aldrich-introduces-the-myriascreen-diversity-collection-for-drug-discovery-2/</guid>
		<description><![CDATA[TimTec and Sigma-Aldrich (NASDAQ:SIAL) are pleased to announce the availability of the MyriaScreen Diversity Collection of drug-like screening compounds produced in collaboration, as a result of careful evaluation, filtering, and refinement of selections from each of our screening compound collections. The MyriaScreen Diversity Collection is comprised of 10,000 high-purity screening compounds handpicked to maximize chemical [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/09/23/sigma-aldrich-introduces-the-myriascreen-diversity-collection-for-drug-discovery-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

